Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States
dc.contributor.author | Tavakkoli, Anna | |
dc.contributor.author | Singal, Amit G. | |
dc.contributor.author | Waljee, Akbar K. | |
dc.contributor.author | Scheiman, James M. | |
dc.contributor.author | Murphy, Caitlin C. | |
dc.contributor.author | Pruitt, Sandi L. | |
dc.contributor.author | Xuan, Lei | |
dc.contributor.author | Kwon, Richard S. | |
dc.contributor.author | Law, Ryan J. | |
dc.contributor.author | Elta, Grace H. | |
dc.contributor.author | Wright‐slaughter, Phyllis | |
dc.contributor.author | Valley, Thomas S. | |
dc.contributor.author | Kubiliun, Nisa | |
dc.contributor.author | Nathan, Hari | |
dc.contributor.author | Rubenstein, Joel H. | |
dc.contributor.author | Elmunzer, B. Joseph | |
dc.date.accessioned | 2019-07-03T19:57:32Z | |
dc.date.available | WITHHELD_13_MONTHS | |
dc.date.available | 2019-07-03T19:57:32Z | |
dc.date.issued | 2019-07 | |
dc.identifier.citation | Tavakkoli, Anna; Singal, Amit G.; Waljee, Akbar K.; Scheiman, James M.; Murphy, Caitlin C.; Pruitt, Sandi L.; Xuan, Lei; Kwon, Richard S.; Law, Ryan J.; Elta, Grace H.; Wright‐slaughter, Phyllis ; Valley, Thomas S.; Kubiliun, Nisa; Nathan, Hari; Rubenstein, Joel H.; Elmunzer, B. Joseph (2019). "Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States." Cancer Medicine 8(7): 3420-3427. | |
dc.identifier.issn | 2045-7634 | |
dc.identifier.issn | 2045-7634 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/149758 | |
dc.description.abstract | BackgroundPancreatic cancer is projected to become the second leading cause of cancerâ related deaths by 2030. Endoscopic retrograde cholangiopancreatography (ERCP) is recommended as firstâ line therapy for biliary decompression in pancreatic cancer. The aim of our study was to characterize geographic and racial/ethnic disparities in ERCP utilization among patients with pancreatic cancer.MethodsRetrospective cohort study using the US Surveillance, Epidemiology, and End Results (SEER)â Medicare database to identify patients diagnosed with pancreatic cancer from 2003â 2013. The primary outcome was receipt of ERCP, with or without stent placement, vs any nonâ ERCP biliary intervention.ResultsOf the 36 619 patients with pancreatic cancer, 37.5% (n = 13 719) underwent an ERCP, percutaneous drainage, or surgical biliary bypass. The most common biliary intervention (82.6%) was ERCP. After adjusting for tumor location and stage, Blacks were significantly less likely to receive ERCP than Whites (aOR 0.84, 95% CI 0.72, 0.97) and more likely to receive percutaneous transhepatic biliary drainage (PTBD) (aOR 1.38, 95% CI 1.14, 1.66). Patients in the Southeast and the West were more likely to receive ERCP than those in the Northeast (Southeast aOR 1.21, 95% CI 1.04, 1.40; West aOR 1.16, 95% CI 1.01, 1.32).ConclusionRacial/ethnic and geographic disparities in access to biliary interventions including ERCP exist for patients with pancreatic cancer in the United States. Our results highlight the need for further research and policies to improve access to appropriate biliary intervention for all patients.To date, disparities in the receipt of endoscopic therapies among patients with pancreatic cancer have not been reported. The results from our study suggest that blacks with pancreatic cancer and patients in the Northeast region of the US are less likely to receive the gold standard therapy for obstructive jaundice. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | disparities | |
dc.subject.other | obstructive jaundice | |
dc.subject.other | ERCP | |
dc.subject.other | pancreatic cancer | |
dc.title | Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Hematology and Oncology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/149758/1/cam42225_am.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/149758/2/cam42225.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/149758/3/cam42225-sup-0001-Supinfo.pdf | |
dc.identifier.doi | 10.1002/cam4.2225 | |
dc.identifier.source | Cancer Medicine | |
dc.identifier.citedreference | SEER-Medicare: Defining the Date of Diagnosis & Treatment. https://healthcaredelivery.cancer.gov/seermedicare/considerations/date.html. | |
dc.identifier.citedreference | Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018; 68: 7 â 30. | |
dc.identifier.citedreference | Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014; 74: 2913 â 2921. | |
dc.identifier.citedreference | Gores GJ, Lieberman D. Good Newsâ Bad News: Current Status of GI Cancers. Gastroenterology. 2016; 151: 13 â 16. | |
dc.identifier.citedreference | Rahman SH, Urquhart R, Molinari M. Neoadjuvant therapy for resectable pancreatic cancer. World J Gastrointest Oncol. 2017; 9: 457 â 465. | |
dc.identifier.citedreference | Floyd J, Mirza I, Sachs B, Perry MC. Hepatotoxicity of chemotherapy. Semin Oncol. 2006; 33: 50 â 67. | |
dc.identifier.citedreference | Artifon E, Sakai P, Cunha J, et al. Surgery or endoscopy for palliation of biliary obstruction due to metastatic pancreatic cancer. Am J Gastroenterol. 2006; 101: 2031 â 2037. | |
dc.identifier.citedreference | Inamdar S, Slattery E, Bhalla R, Sejpal DV, Trindade AJ. Comparison of adverse events for endoscopic vs percutaneous biliary drainage in the treatment of malignant biliary tract obstruction in an inpatient national cohort. JAMA Oncol. 2016; 2: 112 â 117. | |
dc.identifier.citedreference | Bilimoria KY, Bentrem DJ, Ko CY, et al. National failure to operate on early stage pancreatic cancer. Ann. Surg. 2007; 246: 173 â 180. | |
dc.identifier.citedreference | Shapiro M, Chen QI, Huang Q, et al. Associations of socioeconomic variables with resection, stage, and survival in patients with earlyâ stage pancreatic cancer. JAMA Surg. 2016; 151: 338 â 345. | |
dc.identifier.citedreference | Riall TS, Townsend CM, Kuo Yâ F, Freeman JL, Goodwin JS. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2â step process. Cancer. 2010; 116: 930 â 939. | |
dc.identifier.citedreference | Murphy MM, Simons JP, Hill JS, et al. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma. Cancer. 2009; 115: 3979 â 3990. | |
dc.identifier.citedreference | Murphy MM, Simons JP, Ng SC, et al. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma. Ann. Surg. Oncol. 2009; 16: 2968 â 2977. | |
dc.identifier.citedreference | Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEERâ Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002; 40: IVâ 3â 18. | |
dc.identifier.citedreference | Bliss LA, Eskander MF, Kent TS, et al. Early surgical bypass versus endoscopic stent placement in pancreatic cancer. HPB (Oxford). 2016; 18: 671 â 677. | |
dc.identifier.citedreference | Jinkins LJ, Parmar AD, Han Y, et al. Current trends in preoperative biliary stenting in patients with pancreatic cancer. Surgery. 2013; 154: 179 â 189. | |
dc.identifier.citedreference | Nipp R, Tramontano AC, Kong CY, et al. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Cancer Med. 2018; 7: 525 â 535. | |
dc.identifier.citedreference | Census Regions and Divisions of the United States. 2000; 1 â 2. https://www2.census.gov/geo/pdfs/mapsdata/maps/reference/us_regdiv.pdf. | |
dc.identifier.citedreference | Lin CC, Virgo KS. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment. Med Care. 2014; 52: 32 â 37. | |
dc.identifier.citedreference | ASGE Standards of Practice Committee; Eloubeidi MA, Decker GA, et al. The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia. Gastrointest. Endosc. 2016; 83: 17 â 28. | |
dc.identifier.citedreference | Bilimoria KY, Bentrem DJ, Ko CY, et al. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007; 246: 173 â 180. | |
dc.identifier.citedreference | Zell JA, Rhee JM, Ziogas A, Lipkin SM, Antonâ Culver H. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol. Biomarkers Prev. 2007; 16: 546 â 552. | |
dc.identifier.citedreference | Nathan H, Pawlik TM. Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol. 2008; 15: 415 â 423. | |
dc.identifier.citedreference | Ahmed M, Kanotra R, Savani G, et al. Utilization trends in inpatient endoscopic retrograde cholangiopancreatography (ERCP): a crossâ sectional US experience. Endosc Int Open. 2017; 5: E261 â E271. | |
dc.identifier.citedreference | Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2018. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.